{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:51:19Z","timestamp":1790265079859,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.brainres.2009.02.040","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T04:21:22Z","timestamp":1236226882000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Levetiracetam enhances endogenous antioxidant in the hippocampus of rats: In vivo evaluation by brain microdialysis combined with ESR spectroscopy"],"prefix":"10.1016","volume":"1266","author":[{"given":"Yuto","family":"Ueda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuko","family":"Takaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Nagatomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. James","family":"Willmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2009.02.040_bib1","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1468-1331.2007.01907.x","article-title":"Levetiracetam monotherapy in Alzheimer patients with late-onset seizures: a prospective observational study","volume":"14","author":"Belcastro","year":"2007","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.brainres.2009.02.040_bib2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0006-8993(03)02720-3","article-title":"Expression of brain-derived neurotrophic factor (BDNF) and inducible nitric oxide synthase (iNOS) in rat astrocyte cultures treated with levetiracetam","volume":"976","author":"Cardile","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2009.02.040_bib3","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00415-005-0726-y","article-title":"Effects of levetiracetam on the production of nitric oxide\u2014an in vivo study","volume":"252","author":"Dagonnier","year":"2005","journal-title":"J. Neurol."},{"key":"10.1016\/j.brainres.2009.02.040_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejphar.2003.08.033","article-title":"Localization and photoaffinity labelling of the levetiracetam binding site in rat brain and certain cell lines","volume":"478","author":"Fuks","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2009.02.040_bib5","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.eplepsyres.2006.09.005","article-title":"Administration of levetiracetam after prolonged status epilepticus does not protect from mitochondrial dysfunction in a rodent model","volume":"73","author":"Gibbs","year":"2007","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.brainres.2009.02.040_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2003.08.032","article-title":"Binding characteristics of [3H]ucb 30889 to levetiracetam binding sites in rat brain","volume":"478","author":"Gillard","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2009.02.040_bib7","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1053\/seiz.2000.0511","article-title":"Neuroprotective properties of the novel antiepileptic drug levetiracetam in the rat middle cerebral artery occlusion model of focal cerebral ischemia","volume":"10","author":"Hanon","year":"2001","journal-title":"Seizure"},{"key":"10.1016\/j.brainres.2009.02.040_bib8","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1528-1167.2006.00838.x","article-title":"Altered glutamate receptor \u2014 transporter expression and spontaneous seizures in rats exposed to methylazoxymethanol in utero","volume":"48","author":"Harrington","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.brainres.2009.02.040_bib9","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.yebeh.2008.04.025","article-title":"Levetiracetam monotherapy for late poststroke seizures in the elderly","volume":"13","author":"Kutlu","year":"2008","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.brainres.2009.02.040_bib10","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.bbrc.2007.10.036","article-title":"Differential regulation of cell proliferation in neurogenic zones in mice lacking cystine transport by xCT","volume":"364","author":"Liu","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.brainres.2009.02.040_bib11","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0022-3565(24)37251-9","article-title":"Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy","volume":"284","author":"Loscher","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2009.02.040_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1528-1157.2002.24501.x","article-title":"Selective blockade of N-type calcium channels by levetiracetam","volume":"43","author":"Lukyanetz","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.brainres.2009.02.040_bib13","doi-asserted-by":"crossref","first-page":"9861","DOI":"10.1073\/pnas.0308208101","article-title":"The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam","volume":"101","author":"Lynch","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.brainres.2009.02.040_bib14","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.lfs.2003.08.006","article-title":"Levetiracetam protects against kainic acid-induced toxicity","volume":"74","author":"Marini","year":"2004","journal-title":"Life Sci."},{"key":"10.1016\/j.brainres.2009.02.040_bib15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(01)01884-5","article-title":"Levetiracetam inhibits the high-voltage-activated Ca(2+) current in pyramidal neurones of rat hippocampal slices","volume":"306","author":"Niespodziany","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2009.02.040_bib16","series-title":"Stereotaxic Atlas of the Rat Brain","author":"Pellegrino","year":"1986"},{"key":"10.1016\/j.brainres.2009.02.040_bib17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0304-3940(02)01193-X","article-title":"Neuroprotective effects of anticonvulsants in rat hippocampal slice cultures exposed to oxygen\/glucose deprivation","volume":"335","author":"Rekling","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2009.02.040_bib18","first-page":"94","article-title":"Is levetiracetam distinct from conventional antiepileptic drugs in antiepileptogenic properties in spontaneous epileptic rats?","volume":"46","author":"Sasa","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.brainres.2009.02.040_bib19","doi-asserted-by":"crossref","first-page":"10514","DOI":"10.1523\/JNEUROSCI.3178-06.2006","article-title":"Cystine\/glutamate exchange modulates glutathione supply for neuroprotection from oxidative stress and cell proliferation","volume":"26","author":"Shih","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2009.02.040_bib20","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.4088\/JCP.v65n0901","article-title":"Psychopharmacology of anticonvulsants: levetiracetam as a synaptic vesicle protein modulator","volume":"65","author":"Stahl","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.brainres.2009.02.040_bib21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0920-1211(02)00254-1","article-title":"Effects of lamotrigine and levetiracetam on seizure development in a rat amygdala kindling model","volume":"53","author":"Stratton","year":"2003","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.brainres.2009.02.040_bib22","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/sj.bjp.0704141","article-title":"A microdialysis study of the novel antiepileptic drug levetiracetam: extracellular pharmacokinetics and effect on taurine in rat brain","volume":"133","author":"Tong","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainres.2009.02.040_bib23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.brainres.2007.12.069","article-title":"HIF-1-regulated vasoactive systems are differentially involved in acute hypoxic stress responses of the developing brain of newborn mice and are not affected by levetiracetam","volume":"1199","author":"Trollmann","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2009.02.040_bib24","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/mrm.1910400321","article-title":"ESR spectroscopy for analysis of hippocampal elimination of a nitroxide radical during kainic acid-induced seizure in rats","volume":"40","author":"Ueda","year":"1998","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.brainres.2009.02.040_bib25","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1046\/j.1471-4159.2001.00087.x","article-title":"Collapse of extracellular glutamate regulation during epileptogenesis: down-regulation and functional failure of glutamate transporter function in rats with chronic seizures induced by kainic acid","volume":"76","author":"Ueda","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2009.02.040_bib26","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1023\/B:NERE.0000035804.80383.a1","article-title":"Kinetics of extracellular nitroxide radical and glutamate levels in the hippocampus of conscious rats: cautionary note to the application of nitroxide radical on clinical arena","volume":"29","author":"Ueda","year":"2004","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.brainres.2009.02.040_bib27","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s11064-005-7586-9","article-title":"In vivo evaluation of the effect of zonisamide on the hippocampal redox state during kainic acid-induced seizure status in rats","volume":"30","author":"Ueda","year":"2005","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.brainres.2009.02.040_bib28","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.brainres.2007.03.021","article-title":"Effect of levetiracetam on molecular regulation of hippocampal glutamate and GABA transporters in rats with chronic seizures induced by amygdalar FeCl(3) injection","volume":"1151","author":"Ueda","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2009.02.040_bib29","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1385\/NCC:5:1:71","article-title":"Levetiracetam is neuroprotective in murine models of closed head injury and subarachnoid hemorrhage","volume":"5","author":"Wang","year":"2006","journal-title":"Neurocrit. Care"},{"key":"10.1016\/j.brainres.2009.02.040_bib30","doi-asserted-by":"crossref","first-page":"24553","DOI":"10.1074\/jbc.M600939200","article-title":"Glutamate inhibits chondral mineralization through apoptotic cell death mediated by retrograde operation of the cystine\/glutamate antiporter","volume":"281","author":"Wang","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2009.02.040_bib31","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0891-5849(99)00093-3","article-title":"EPR imaging for in vivo analysis of the half-life of a nitroxide radical in the hippocampus and cerebral cortex of rats after epileptic seizures","volume":"27","author":"Yokoyama","year":"1999","journal-title":"Free Radic. Biol. Med."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899309004156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899309004156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T17:38:26Z","timestamp":1757785106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899309004156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":31,"alternative-id":["S0006899309004156"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2009.02.040","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levetiracetam enhances endogenous antioxidant in the hippocampus of rats: In vivo evaluation by brain microdialysis combined with ESR spectroscopy","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2009.02.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}